Loading…

Diabetes‐induced changes in the 5‐hydroxytryptamine inhibitory receptors involved in the pressor effect elicited by sympathetic stimulation in the pithed rat

1 We investigated the effect of alloxan‐induced diabetes on the inhibitory mechanisms of 5‐hydroxytryptamine (5‐HT) in the pressor responses induced by stimulation of sympathetic vasopressor outflow in pithed rats, and analysed the type and/or subtype of 5‐HT receptors involved. 2 Diabetes was induc...

Full description

Saved in:
Bibliographic Details
Published in:British journal of pharmacology 2005-07, Vol.145 (5), p.593-601
Main Authors: García, Mónica, Morán, Asunción, Calama, Elena, Martín, Maria Luisa, Barthelmebs, Mariette, Román, Luis San
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4890-36428785aedb9193257f35d37cbc4e6bf22fe836337032671ebaa86449595eab3
cites cdi_FETCH-LOGICAL-c4890-36428785aedb9193257f35d37cbc4e6bf22fe836337032671ebaa86449595eab3
container_end_page 601
container_issue 5
container_start_page 593
container_title British journal of pharmacology
container_volume 145
creator García, Mónica
Morán, Asunción
Calama, Elena
Martín, Maria Luisa
Barthelmebs, Mariette
Román, Luis San
description 1 We investigated the effect of alloxan‐induced diabetes on the inhibitory mechanisms of 5‐hydroxytryptamine (5‐HT) in the pressor responses induced by stimulation of sympathetic vasopressor outflow in pithed rats, and analysed the type and/or subtype of 5‐HT receptors involved. 2 Diabetes was induced in male Wistar rats by a single s.c. injection of alloxan, then 4 weeks later, they were anaesthetized, pretreated with atropine and pithed. Electrical stimulation of the sympathetic outflow from the spinal cord (0.1, 0.5, 1 and 5 Hz) resulted in frequency‐dependent increases in blood pressure. 3 Intravenous infusions of 5‐HT (1–80 μg kg−1 min−1) reduced the pressor effects obtained by electrical stimulation. The 5‐HT1 receptor agonist 5‐carboxamidotryptamine, 5‐CT (5 μg kg−1 min−1), caused an inhibition of the pressor response, whereas the selective 5‐HT2 receptor agonist, α‐methyl‐5‐HT (5 μg kg−1 min−1) and the selective 5‐HT3 receptor agonist, 1‐phenylbiguanide (40 μg kg−1 min−1), did not modify the sympathetic pressor responses. 5‐HT had no effect on exogenous noradrenaline (NA)‐induced pressor responses. 4 The inhibition of electrically induced pressor responses by 5‐HT (10 μg kg−1 min−1) was unable to be elicited after i.v. treatment with methiothepin (100 μg kg−1) because of the marked inhibition produced by methiothepin alone. The 5‐HT‐induced inhibition was blocked after i.v. administration of WAY‐100,635 (100 μg kg−1) and not affected by ritanserin (1 mg kg−1), MDL 72222 (2 mg kg−1). 5 The selective 5‐HT1A receptor agonist, 8‐hydroxydipropylaminotretalin hydrobromide (8‐OH‐DPAT) (5–20 μg kg−1 min−1) but neither the rodent 5‐HT1B receptor agonist, CGS‐12066B (5 μg kg−1 min−1), nor the selective nonrodent 5‐HT1B and 5‐HT1D receptor agonist, L‐694,247 (5 and 40 μg kg−1 min−1), inhibited the electrically induced pressor response. The selective 5‐HT1A receptor antagonist, WAY‐100,635 (100 μg kg−1), blocked the inhibition induced by 8‐OH‐DPAT (10 μg kg−1 min−1). 8‐OH‐DPAT had no effect on exogenous NA‐induced pressor responses. 6 Experimental diabetes produces changes in the inhibitory effect induced by 5‐HT on electrically induced sympathetic pressor responses, such that the inhibitory action induced by 5‐HT in diabetic pithed rats is mediated by prejunctional 5‐HT1A receptors. British Journal of Pharmacology (2005) 145, 593–601. doi:10.1038/sj.bjp.0706216
doi_str_mv 10.1038/sj.bjp.0706216
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1576173</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>971572831</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4890-36428785aedb9193257f35d37cbc4e6bf22fe836337032671ebaa86449595eab3</originalsourceid><addsrcrecordid>eNqFkctu1TAURS0EopfClCGykBjm4kccJxMkWh5FqgQDGFu2c9I4ygvbuZBZP6G_wK_xJbi6UQsjJralvfY-R94IPadkTwkvX4dub7p5TyQpGC0eoB3NZZEJXtKHaEcIkRmlZXmCnoTQEZJEKR6jEypKwQivdujXO6cNRAi_r2_cWC8WamxbPV5BwG7EsQUsktSutZ9-rtGvc9SDGyGJrTMuTn7FHizM6XXrOEz9IUVs1tlDCJPH0DRgI4beWReTbFYc1mHWiYnO4hDdsPQ6umm8c7p01tjr-BQ9anQf4Nl2n6JvH95_Pb_ILj9__HT-9jKzeVmRjBc5K2UpNNSmohVnQjZc1FxaY3MoTMNYAyUvOJeEs0JSMFqXRZ5XohKgDT9Fb46582IGqC2M0etezd4N2q9q0k79q4yuVVfTQVEhCyp5Cni5Bfjp-wIhqm5a_Jh2VoxKWrFKsgTtj5D1UwgemrsBlKjbRlXoVGpUbY0mw4u_17rHtwoT8GoDdLC6b7werQv3XFFxnsISx4_cD9fD-p-x6uzLBUvfyv8ADXPBUg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>217192972</pqid></control><display><type>article</type><title>Diabetes‐induced changes in the 5‐hydroxytryptamine inhibitory receptors involved in the pressor effect elicited by sympathetic stimulation in the pithed rat</title><source>PubMed (Medline)</source><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>García, Mónica ; Morán, Asunción ; Calama, Elena ; Martín, Maria Luisa ; Barthelmebs, Mariette ; Román, Luis San</creator><creatorcontrib>García, Mónica ; Morán, Asunción ; Calama, Elena ; Martín, Maria Luisa ; Barthelmebs, Mariette ; Román, Luis San</creatorcontrib><description>1 We investigated the effect of alloxan‐induced diabetes on the inhibitory mechanisms of 5‐hydroxytryptamine (5‐HT) in the pressor responses induced by stimulation of sympathetic vasopressor outflow in pithed rats, and analysed the type and/or subtype of 5‐HT receptors involved. 2 Diabetes was induced in male Wistar rats by a single s.c. injection of alloxan, then 4 weeks later, they were anaesthetized, pretreated with atropine and pithed. Electrical stimulation of the sympathetic outflow from the spinal cord (0.1, 0.5, 1 and 5 Hz) resulted in frequency‐dependent increases in blood pressure. 3 Intravenous infusions of 5‐HT (1–80 μg kg−1 min−1) reduced the pressor effects obtained by electrical stimulation. The 5‐HT1 receptor agonist 5‐carboxamidotryptamine, 5‐CT (5 μg kg−1 min−1), caused an inhibition of the pressor response, whereas the selective 5‐HT2 receptor agonist, α‐methyl‐5‐HT (5 μg kg−1 min−1) and the selective 5‐HT3 receptor agonist, 1‐phenylbiguanide (40 μg kg−1 min−1), did not modify the sympathetic pressor responses. 5‐HT had no effect on exogenous noradrenaline (NA)‐induced pressor responses. 4 The inhibition of electrically induced pressor responses by 5‐HT (10 μg kg−1 min−1) was unable to be elicited after i.v. treatment with methiothepin (100 μg kg−1) because of the marked inhibition produced by methiothepin alone. The 5‐HT‐induced inhibition was blocked after i.v. administration of WAY‐100,635 (100 μg kg−1) and not affected by ritanserin (1 mg kg−1), MDL 72222 (2 mg kg−1). 5 The selective 5‐HT1A receptor agonist, 8‐hydroxydipropylaminotretalin hydrobromide (8‐OH‐DPAT) (5–20 μg kg−1 min−1) but neither the rodent 5‐HT1B receptor agonist, CGS‐12066B (5 μg kg−1 min−1), nor the selective nonrodent 5‐HT1B and 5‐HT1D receptor agonist, L‐694,247 (5 and 40 μg kg−1 min−1), inhibited the electrically induced pressor response. The selective 5‐HT1A receptor antagonist, WAY‐100,635 (100 μg kg−1), blocked the inhibition induced by 8‐OH‐DPAT (10 μg kg−1 min−1). 8‐OH‐DPAT had no effect on exogenous NA‐induced pressor responses. 6 Experimental diabetes produces changes in the inhibitory effect induced by 5‐HT on electrically induced sympathetic pressor responses, such that the inhibitory action induced by 5‐HT in diabetic pithed rats is mediated by prejunctional 5‐HT1A receptors. British Journal of Pharmacology (2005) 145, 593–601. doi:10.1038/sj.bjp.0706216</description><identifier>ISSN: 0007-1188</identifier><identifier>EISSN: 1476-5381</identifier><identifier>DOI: 10.1038/sj.bjp.0706216</identifier><identifier>PMID: 15852039</identifier><identifier>CODEN: BJPCBM</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>5‐CT ; 5‐HT1A receptors ; 5‐Hydroxytryptamine ; Animals ; Atropine - pharmacology ; Biological and medical sciences ; Blood Glucose - metabolism ; Blood Pressure - drug effects ; Blood Pressure - physiology ; Body Weight - drug effects ; Decerebrate State - physiopathology ; Diabetes Mellitus, Experimental - metabolism ; Dose-Response Relationship, Drug ; experimental diabetes ; Hemodynamics - drug effects ; Male ; Medical sciences ; Parasympatholytics - pharmacology ; Pharmacology. Drug treatments ; prejunctional inhibition ; Rats ; Rats, Wistar ; Receptor, Serotonin, 5-HT1A - drug effects ; Receptors, Serotonin - drug effects ; Receptors, Serotonin - physiology ; Receptors, Serotonin, 5-HT1 - drug effects ; Serotonin Antagonists - pharmacology ; Serotonin Receptor Agonists - pharmacology ; Stimulation, Chemical ; Sympathetic Nervous System - physiology</subject><ispartof>British journal of pharmacology, 2005-07, Vol.145 (5), p.593-601</ispartof><rights>2005 British Pharmacological Society</rights><rights>2005 INIST-CNRS</rights><rights>Copyright Nature Publishing Group Jul 2005</rights><rights>Copyright 2005, Nature Publishing Group 2005 Nature Publishing Group</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4890-36428785aedb9193257f35d37cbc4e6bf22fe836337032671ebaa86449595eab3</citedby><cites>FETCH-LOGICAL-c4890-36428785aedb9193257f35d37cbc4e6bf22fe836337032671ebaa86449595eab3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1576173/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1576173/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16933070$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15852039$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>García, Mónica</creatorcontrib><creatorcontrib>Morán, Asunción</creatorcontrib><creatorcontrib>Calama, Elena</creatorcontrib><creatorcontrib>Martín, Maria Luisa</creatorcontrib><creatorcontrib>Barthelmebs, Mariette</creatorcontrib><creatorcontrib>Román, Luis San</creatorcontrib><title>Diabetes‐induced changes in the 5‐hydroxytryptamine inhibitory receptors involved in the pressor effect elicited by sympathetic stimulation in the pithed rat</title><title>British journal of pharmacology</title><addtitle>Br J Pharmacol</addtitle><description>1 We investigated the effect of alloxan‐induced diabetes on the inhibitory mechanisms of 5‐hydroxytryptamine (5‐HT) in the pressor responses induced by stimulation of sympathetic vasopressor outflow in pithed rats, and analysed the type and/or subtype of 5‐HT receptors involved. 2 Diabetes was induced in male Wistar rats by a single s.c. injection of alloxan, then 4 weeks later, they were anaesthetized, pretreated with atropine and pithed. Electrical stimulation of the sympathetic outflow from the spinal cord (0.1, 0.5, 1 and 5 Hz) resulted in frequency‐dependent increases in blood pressure. 3 Intravenous infusions of 5‐HT (1–80 μg kg−1 min−1) reduced the pressor effects obtained by electrical stimulation. The 5‐HT1 receptor agonist 5‐carboxamidotryptamine, 5‐CT (5 μg kg−1 min−1), caused an inhibition of the pressor response, whereas the selective 5‐HT2 receptor agonist, α‐methyl‐5‐HT (5 μg kg−1 min−1) and the selective 5‐HT3 receptor agonist, 1‐phenylbiguanide (40 μg kg−1 min−1), did not modify the sympathetic pressor responses. 5‐HT had no effect on exogenous noradrenaline (NA)‐induced pressor responses. 4 The inhibition of electrically induced pressor responses by 5‐HT (10 μg kg−1 min−1) was unable to be elicited after i.v. treatment with methiothepin (100 μg kg−1) because of the marked inhibition produced by methiothepin alone. The 5‐HT‐induced inhibition was blocked after i.v. administration of WAY‐100,635 (100 μg kg−1) and not affected by ritanserin (1 mg kg−1), MDL 72222 (2 mg kg−1). 5 The selective 5‐HT1A receptor agonist, 8‐hydroxydipropylaminotretalin hydrobromide (8‐OH‐DPAT) (5–20 μg kg−1 min−1) but neither the rodent 5‐HT1B receptor agonist, CGS‐12066B (5 μg kg−1 min−1), nor the selective nonrodent 5‐HT1B and 5‐HT1D receptor agonist, L‐694,247 (5 and 40 μg kg−1 min−1), inhibited the electrically induced pressor response. The selective 5‐HT1A receptor antagonist, WAY‐100,635 (100 μg kg−1), blocked the inhibition induced by 8‐OH‐DPAT (10 μg kg−1 min−1). 8‐OH‐DPAT had no effect on exogenous NA‐induced pressor responses. 6 Experimental diabetes produces changes in the inhibitory effect induced by 5‐HT on electrically induced sympathetic pressor responses, such that the inhibitory action induced by 5‐HT in diabetic pithed rats is mediated by prejunctional 5‐HT1A receptors. British Journal of Pharmacology (2005) 145, 593–601. doi:10.1038/sj.bjp.0706216</description><subject>5‐CT</subject><subject>5‐HT1A receptors</subject><subject>5‐Hydroxytryptamine</subject><subject>Animals</subject><subject>Atropine - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Blood Glucose - metabolism</subject><subject>Blood Pressure - drug effects</subject><subject>Blood Pressure - physiology</subject><subject>Body Weight - drug effects</subject><subject>Decerebrate State - physiopathology</subject><subject>Diabetes Mellitus, Experimental - metabolism</subject><subject>Dose-Response Relationship, Drug</subject><subject>experimental diabetes</subject><subject>Hemodynamics - drug effects</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Parasympatholytics - pharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>prejunctional inhibition</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Receptor, Serotonin, 5-HT1A - drug effects</subject><subject>Receptors, Serotonin - drug effects</subject><subject>Receptors, Serotonin - physiology</subject><subject>Receptors, Serotonin, 5-HT1 - drug effects</subject><subject>Serotonin Antagonists - pharmacology</subject><subject>Serotonin Receptor Agonists - pharmacology</subject><subject>Stimulation, Chemical</subject><subject>Sympathetic Nervous System - physiology</subject><issn>0007-1188</issn><issn>1476-5381</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNqFkctu1TAURS0EopfClCGykBjm4kccJxMkWh5FqgQDGFu2c9I4ygvbuZBZP6G_wK_xJbi6UQsjJralvfY-R94IPadkTwkvX4dub7p5TyQpGC0eoB3NZZEJXtKHaEcIkRmlZXmCnoTQEZJEKR6jEypKwQivdujXO6cNRAi_r2_cWC8WamxbPV5BwG7EsQUsktSutZ9-rtGvc9SDGyGJrTMuTn7FHizM6XXrOEz9IUVs1tlDCJPH0DRgI4beWReTbFYc1mHWiYnO4hDdsPQ6umm8c7p01tjr-BQ9anQf4Nl2n6JvH95_Pb_ILj9__HT-9jKzeVmRjBc5K2UpNNSmohVnQjZc1FxaY3MoTMNYAyUvOJeEs0JSMFqXRZ5XohKgDT9Fb46582IGqC2M0etezd4N2q9q0k79q4yuVVfTQVEhCyp5Cni5Bfjp-wIhqm5a_Jh2VoxKWrFKsgTtj5D1UwgemrsBlKjbRlXoVGpUbY0mw4u_17rHtwoT8GoDdLC6b7werQv3XFFxnsISx4_cD9fD-p-x6uzLBUvfyv8ADXPBUg</recordid><startdate>200507</startdate><enddate>200507</enddate><creator>García, Mónica</creator><creator>Morán, Asunción</creator><creator>Calama, Elena</creator><creator>Martín, Maria Luisa</creator><creator>Barthelmebs, Mariette</creator><creator>Román, Luis San</creator><general>Blackwell Publishing Ltd</general><general>Nature Publishing</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope></search><sort><creationdate>200507</creationdate><title>Diabetes‐induced changes in the 5‐hydroxytryptamine inhibitory receptors involved in the pressor effect elicited by sympathetic stimulation in the pithed rat</title><author>García, Mónica ; Morán, Asunción ; Calama, Elena ; Martín, Maria Luisa ; Barthelmebs, Mariette ; Román, Luis San</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4890-36428785aedb9193257f35d37cbc4e6bf22fe836337032671ebaa86449595eab3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>5‐CT</topic><topic>5‐HT1A receptors</topic><topic>5‐Hydroxytryptamine</topic><topic>Animals</topic><topic>Atropine - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Blood Glucose - metabolism</topic><topic>Blood Pressure - drug effects</topic><topic>Blood Pressure - physiology</topic><topic>Body Weight - drug effects</topic><topic>Decerebrate State - physiopathology</topic><topic>Diabetes Mellitus, Experimental - metabolism</topic><topic>Dose-Response Relationship, Drug</topic><topic>experimental diabetes</topic><topic>Hemodynamics - drug effects</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Parasympatholytics - pharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>prejunctional inhibition</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Receptor, Serotonin, 5-HT1A - drug effects</topic><topic>Receptors, Serotonin - drug effects</topic><topic>Receptors, Serotonin - physiology</topic><topic>Receptors, Serotonin, 5-HT1 - drug effects</topic><topic>Serotonin Antagonists - pharmacology</topic><topic>Serotonin Receptor Agonists - pharmacology</topic><topic>Stimulation, Chemical</topic><topic>Sympathetic Nervous System - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>García, Mónica</creatorcontrib><creatorcontrib>Morán, Asunción</creatorcontrib><creatorcontrib>Calama, Elena</creatorcontrib><creatorcontrib>Martín, Maria Luisa</creatorcontrib><creatorcontrib>Barthelmebs, Mariette</creatorcontrib><creatorcontrib>Román, Luis San</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>García, Mónica</au><au>Morán, Asunción</au><au>Calama, Elena</au><au>Martín, Maria Luisa</au><au>Barthelmebs, Mariette</au><au>Román, Luis San</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diabetes‐induced changes in the 5‐hydroxytryptamine inhibitory receptors involved in the pressor effect elicited by sympathetic stimulation in the pithed rat</atitle><jtitle>British journal of pharmacology</jtitle><addtitle>Br J Pharmacol</addtitle><date>2005-07</date><risdate>2005</risdate><volume>145</volume><issue>5</issue><spage>593</spage><epage>601</epage><pages>593-601</pages><issn>0007-1188</issn><eissn>1476-5381</eissn><coden>BJPCBM</coden><abstract>1 We investigated the effect of alloxan‐induced diabetes on the inhibitory mechanisms of 5‐hydroxytryptamine (5‐HT) in the pressor responses induced by stimulation of sympathetic vasopressor outflow in pithed rats, and analysed the type and/or subtype of 5‐HT receptors involved. 2 Diabetes was induced in male Wistar rats by a single s.c. injection of alloxan, then 4 weeks later, they were anaesthetized, pretreated with atropine and pithed. Electrical stimulation of the sympathetic outflow from the spinal cord (0.1, 0.5, 1 and 5 Hz) resulted in frequency‐dependent increases in blood pressure. 3 Intravenous infusions of 5‐HT (1–80 μg kg−1 min−1) reduced the pressor effects obtained by electrical stimulation. The 5‐HT1 receptor agonist 5‐carboxamidotryptamine, 5‐CT (5 μg kg−1 min−1), caused an inhibition of the pressor response, whereas the selective 5‐HT2 receptor agonist, α‐methyl‐5‐HT (5 μg kg−1 min−1) and the selective 5‐HT3 receptor agonist, 1‐phenylbiguanide (40 μg kg−1 min−1), did not modify the sympathetic pressor responses. 5‐HT had no effect on exogenous noradrenaline (NA)‐induced pressor responses. 4 The inhibition of electrically induced pressor responses by 5‐HT (10 μg kg−1 min−1) was unable to be elicited after i.v. treatment with methiothepin (100 μg kg−1) because of the marked inhibition produced by methiothepin alone. The 5‐HT‐induced inhibition was blocked after i.v. administration of WAY‐100,635 (100 μg kg−1) and not affected by ritanserin (1 mg kg−1), MDL 72222 (2 mg kg−1). 5 The selective 5‐HT1A receptor agonist, 8‐hydroxydipropylaminotretalin hydrobromide (8‐OH‐DPAT) (5–20 μg kg−1 min−1) but neither the rodent 5‐HT1B receptor agonist, CGS‐12066B (5 μg kg−1 min−1), nor the selective nonrodent 5‐HT1B and 5‐HT1D receptor agonist, L‐694,247 (5 and 40 μg kg−1 min−1), inhibited the electrically induced pressor response. The selective 5‐HT1A receptor antagonist, WAY‐100,635 (100 μg kg−1), blocked the inhibition induced by 8‐OH‐DPAT (10 μg kg−1 min−1). 8‐OH‐DPAT had no effect on exogenous NA‐induced pressor responses. 6 Experimental diabetes produces changes in the inhibitory effect induced by 5‐HT on electrically induced sympathetic pressor responses, such that the inhibitory action induced by 5‐HT in diabetic pithed rats is mediated by prejunctional 5‐HT1A receptors. British Journal of Pharmacology (2005) 145, 593–601. doi:10.1038/sj.bjp.0706216</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>15852039</pmid><doi>10.1038/sj.bjp.0706216</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-1188
ispartof British journal of pharmacology, 2005-07, Vol.145 (5), p.593-601
issn 0007-1188
1476-5381
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1576173
source PubMed (Medline); Wiley-Blackwell Read & Publish Collection
subjects 5‐CT
5‐HT1A receptors
5‐Hydroxytryptamine
Animals
Atropine - pharmacology
Biological and medical sciences
Blood Glucose - metabolism
Blood Pressure - drug effects
Blood Pressure - physiology
Body Weight - drug effects
Decerebrate State - physiopathology
Diabetes Mellitus, Experimental - metabolism
Dose-Response Relationship, Drug
experimental diabetes
Hemodynamics - drug effects
Male
Medical sciences
Parasympatholytics - pharmacology
Pharmacology. Drug treatments
prejunctional inhibition
Rats
Rats, Wistar
Receptor, Serotonin, 5-HT1A - drug effects
Receptors, Serotonin - drug effects
Receptors, Serotonin - physiology
Receptors, Serotonin, 5-HT1 - drug effects
Serotonin Antagonists - pharmacology
Serotonin Receptor Agonists - pharmacology
Stimulation, Chemical
Sympathetic Nervous System - physiology
title Diabetes‐induced changes in the 5‐hydroxytryptamine inhibitory receptors involved in the pressor effect elicited by sympathetic stimulation in the pithed rat
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T14%3A47%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diabetes%E2%80%90induced%20changes%20in%20the%205%E2%80%90hydroxytryptamine%20inhibitory%20receptors%20involved%20in%20the%20pressor%20effect%20elicited%20by%20sympathetic%20stimulation%20in%20the%20pithed%20rat&rft.jtitle=British%20journal%20of%20pharmacology&rft.au=Garc%C3%ADa,%20M%C3%B3nica&rft.date=2005-07&rft.volume=145&rft.issue=5&rft.spage=593&rft.epage=601&rft.pages=593-601&rft.issn=0007-1188&rft.eissn=1476-5381&rft.coden=BJPCBM&rft_id=info:doi/10.1038/sj.bjp.0706216&rft_dat=%3Cproquest_pubme%3E971572831%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4890-36428785aedb9193257f35d37cbc4e6bf22fe836337032671ebaa86449595eab3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=217192972&rft_id=info:pmid/15852039&rfr_iscdi=true